Autologous adult bone marrow-derived non-expanded CD133+ haematopoietic stem cells

Autologous adult bone marrow-derived non-expanded CD133+ haematopoietic stem cells
Trade Name
Orphan Indication Asherman's syndrome
EU Market Approval EU
EU Designation Date 2017-04-20 00:00:00
Sponsor Igenomix, S.L.